These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26794842)

  • 1. Prolonged exposure to doxorubicin after radiotherapy in glioblastoma.
    Sardi I
    Future Oncol; 2016 Mar; 12(5):581-3. PubMed ID: 26794842
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
    Lin YL; Wu MT; Yang FY
    J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
    Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy.
    Ananda S; Nowak AK; Cher L; Dowling A; Brown C; Simes J; Rosenthal MA;
    J Clin Neurosci; 2011 Nov; 18(11):1444-8. PubMed ID: 21813279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles.
    Steiniger SC; Kreuter J; Khalansky AS; Skidan IN; Bobruskin AI; Smirnova ZS; Severin SE; Uhl R; Kock M; Geiger KD; Gelperina SE
    Int J Cancer; 2004 May; 109(5):759-67. PubMed ID: 14999786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
    Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
    J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy.
    Yusubalieva GM; Baklaushev VP; Gurina OI; Zorkina YA; Gubskii IL; Kobyakov GL; Golanov AV; Goryainov SA; Gorlachev GE; Konovalov AN; Potapov AA; Chekhonin VP
    Bull Exp Biol Med; 2014 Aug; 157(4):510-5. PubMed ID: 25110095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
    Wang X; Wang L; Tan X; Zhang H; Sun G
    J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
    Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
    Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
    Petri B; Bootz A; Khalansky A; Hekmatara T; Müller R; Uhl R; Kreuter J; Gelperina S
    J Control Release; 2007 Jan; 117(1):51-8. PubMed ID: 17150277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-induced cytotoxicity in the GL261 glioma model system.
    Tavener AM; Phelps MC; Daniels RL
    Mol Biol Rep; 2021 Jan; 48(1):1017-1023. PubMed ID: 33387196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
    Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):353-7. PubMed ID: 15380566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA; Krause M; Zyromska A; Lambin P; Baumann M; Wouters BG
    Radiother Oncol; 2007 Jan; 82(1):96-104. PubMed ID: 17161482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
    Stukel JM; Caplan MR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.